Optimized lentiviral vector to restore full-length dystrophin via a cell-mediated approach in a mouse model of Duchenne muscular dystrophy

Jinhong Meng, Marc Moore, John Counsell, Francesco Muntoni, Linda Popplewell, Jennifer Morgan

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	491-507
Number of pages	17
Journal	Molecular Therapy - Methods and Clinical Development
Volume	25
Early online date	1 May 2022
DOIs	https://doi.org/10.1016/j.omtm.2022.04.015
Publication status	Published - 9 Jun 2022

Access to Document

@article{6a52f8f01ffd442cb885d9a760dc2cb2,

title = "Optimized lentiviral vector to restore full-length dystrophin via a cell-mediated approach in a mouse model of Duchenne muscular dystrophy",

author = "Jinhong Meng and Marc Moore and John Counsell and Francesco Muntoni and Linda Popplewell and Jennifer Morgan",

note = "{\textcopyright} 2022 The Author(s).",

year = "2022",

month = jun,

day = "9",

doi = "10.1016/j.omtm.2022.04.015",

language = "English",

volume = "25",

pages = "491--507",

journal = "Molecular Therapy - Methods and Clinical Development",

issn = "2329-0501",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Optimized lentiviral vector to restore full-length dystrophin via a cell-mediated approach in a mouse model of Duchenne muscular dystrophy

AU - Meng, Jinhong

AU - Moore, Marc

AU - Counsell, John

AU - Muntoni, Francesco

AU - Popplewell, Linda

AU - Morgan, Jennifer

PY - 2022/6/9

Y1 - 2022/6/9

U2 - 10.1016/j.omtm.2022.04.015

DO - 10.1016/j.omtm.2022.04.015

M3 - Article

C2 - 35615709

SN - 2329-0501

VL - 25

SP - 491

EP - 507

JO - Molecular Therapy - Methods and Clinical Development

JF - Molecular Therapy - Methods and Clinical Development

ER -